Please wait...
About This Project
The etiological agent for Chagas' disease is the protozoan parasite Trypanosoma cruzi, which affects 6 - 7 million people primarily in Latin America. The chronic stage of infection causes cardiomyopathy and the enlargement of other organs resulting in disease burden and death. There is an urgent need to replace the clinical therapeutics (benznidazole & nifurtimox) and this proposal focuses on a compound screen to observe a hit expansion with the target T. cruzi glucokinase.
More Lab Notes From This Project

Browse Other Projects on Experiment
Related Projects
Community-based interventions to control urogenital schistosomiasis in dam communities
Urogenital schistosomiasis is a snail-borne infection having a huge socioeconomic impact on underserved...
Metabolizing Microplastics for Human Health
Plastics have revolutionized material science engineering. However, the use of plastic has had unintended...
Can albumin from egg whites be used to treat Clostridium difficile infections?
Clostridium difficile infection is a toxin-mediated bacterial infection responsible for 500,000 infections...